White paper: Guaranteeing High Quality Medicinal Gases In Europe
As European healthcare systems transform to meet rising demand and evolving technologies, so too does the need for a secure, high-quality supply of medicinal gases—vital for patient treatment and emergency care. While on-site gas production offers operational flexibility, it brings new challenges in quality assurance, regulatory compliance, and supply chain resilience.
In this new white paper, the European Industrial Gases Association (EIGA) addresses these vital concerns, advocating for harmonised guidelines within the EU’s General Pharmaceutical Legislation. Discover how EIGA’s recommendations aim to safeguard patient well-being and maintain robust supply chains for medicinal gases across Europe.
This white paper offers crucial insights into the future of medicinal gas provision throughout Europe, whether you’re managing the supply of medicinal gas, regulating pharmaceuticals, or developing healthcare policy.
